Insight Molecular Diagnostics (IMDX) Receivables: 2020-2025
Historic Receivables for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $258,000.
- Insight Molecular Diagnostics' Receivables rose 23.44% to $258,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 530.78%. This contributed to the annual value of $1.6 million for FY2024, which is 233.26% up from last year.
- Insight Molecular Diagnostics' Receivables amounted to $258,000 in Q3 2025, which was down 49.61% from $512,000 recorded in Q2 2025.
- In the past 5 years, Insight Molecular Diagnostics' Receivables registered a high of $3.5 million during Q1 2025, and its lowest value of $85,000 during Q2 2024.
- Moreover, its 3-year median value for Receivables was $512,000 (2025), whereas its average is $858,909.
- Per our database at Business Quant, Insight Molecular Diagnostics' Receivables skyrocketed by 5,307.69% in 2021 and then crashed by 88.50% in 2024.
- Insight Molecular Diagnostics' Receivables (Quarterly) stood at $1.4 million in 2021, then declined by 2.57% to $1.4 million in 2022, then plummeted by 65.43% to $484,000 in 2023, then soared by 233.26% to $1.6 million in 2024, then rose by 23.44% to $258,000 in 2025.
- Its Receivables was $258,000 in Q3 2025, compared to $512,000 in Q2 2025 and $3.5 million in Q1 2025.